ClinicalTrials.gov
public full text
Public Domain
Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
Cutaneous leishmaniasis (CL) is endemic in Israel and is caused by Leishmania major or Leishmania tropica. CL is usually a benign disease and limited to the skin. One of the local treatment available is intralesional (IL) Pentostam injection. During the current study the investigators will monitor the adverse effects of this treatment and will follow up the recovery of the lesions after Pentostam injections.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World#1046219
- Use of Sodium Stibogluconate as a Treatment for Leishmaniasis#888279
- Zoonotic cutaneous leishmaniasis caused by <i>Leishmania major</i> : Do humans play a role in amplifying transmission?#274289
- Decision-making for indoor residual spraying in the post-elimination phase of visceral leishmaniasis in Nepal#203146
- Gambaran Penerapan Kompres Air Hangat Terhadap Penurunan Suhu Tubuh Pada Pasien Demam Tifoid Di Ruang Nuri Rumah Sakit Dr. H. Abdul Moeloek Provinsi Lampung#1003141
Record · ID 1163386
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive